Page last updated: 2024-09-04

tecadenoson and Auricular Fibrillation

tecadenoson has been researched along with Auricular Fibrillation in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	4 (66.67)	29.6817
2010's	2 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ahmed, H; Chu, N; Gao, Z; Ibrahim, P; Leung, K; Li, Z; Ozeck, M; Palle, VP; Varkhedkar, V; Wu, L; Wu, Y; Zablocki, JA; Zeng, D	1
Corino, VD; Holmqvist, F; Mainardi, LT; Platonov, PG	1
Corino, VD; Mainardi, LT; Platonov, PG; Sandberg, F; Sörnmo, L	1
Cheung, JW; Lerman, BB	1
Banchs, JE; Gonzalez, MD; Naccarelli, GV; Penny-Peterson, E; Samii, S; Wolbrette, DL	1
Zaza, A	1

Reviews

3 review(s) available for tecadenoson and Auricular Fibrillation

Article	Year
CVT-510: a selective A1 adenosine receptor agonist. Cardiovascular drug reviews, 2003,Winter, Volume: 21, Issue:4 Topics: Adenosine; Adenosine A1 Receptor Agonists; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Blood Pressure; Furans; Heart Rate; Humans; Receptor, Adenosine A1; Tachycardia, Supraventricular	2003
New antiarrhythmic treatment of atrial fibrillation. Expert review of cardiovascular therapy, 2007, Volume: 5, Issue:4 Topics: Adenosine; Adenosine A1 Receptor Antagonists; Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Benzofurans; Biphenyl Compounds; Bridged Bicyclo Compounds, Heterocyclic; Carbazoles; Carvedilol; Cyclopropanes; Dronedarone; Fatty Acids, Omega-3; Furans; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Oligopeptides; Organic Chemicals; Peptidyl-Dipeptidase A; Potassium Channel Blockers; Propanolamines; Purinergic P1 Receptor Agonists	2007
CVT-510 (CV Therapeutics). Current opinion in investigational drugs (London, England : 2000), 2002, Volume: 3, Issue:1 Topics: Adenosine; Animals; Atrial Fibrillation; Clinical Trials as Topic; Furans; Humans; Purinergic P1 Receptor Agonists; Receptors, Purinergic P1; Tachycardia, Ventricular; Technology, Pharmaceutical	2002

Trials

2 trial(s) available for tecadenoson and Auricular Fibrillation

Article	Year
Beta-blockade and A1-adenosine receptor agonist effects on atrial fibrillatory rate and atrioventricular conduction in patients with atrial fibrillation. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2014, Volume: 16, Issue:4 Topics: Adenosine; Administration, Intravenous; Adrenergic beta-1 Receptor Antagonists; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrioventricular Node; Dose-Response Relationship, Drug; Drug Therapy, Combination; Electrocardiography; Female; Furans; Heart Rate; Humans; Male; Middle Aged; Propanolamines; Purinergic P1 Receptor Agonists; Time Factors; Treatment Outcome	2014
Noninvasive Assessment of Atrioventricular Nodal Function: Effect of Rate-Control Drugs during Atrial Fibrillation. Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc, 2015, Volume: 20, Issue:6 Topics: Adenosine; Adrenergic beta-1 Receptor Antagonists; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrioventricular Node; Female; Furans; Humans; Male; Middle Aged; Propanolamines; Purinergic P1 Receptor Agonists	2015

Article

Year

Beta-blockade and A1-adenosine receptor agonist effects on atrial fibrillatory rate and atrioventricular conduction in patients with atrial fibrillation.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2014, Volume: 16, Issue:4

Topics: Adenosine; Administration, Intravenous; Adrenergic beta-1 Receptor Antagonists; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrioventricular Node; Dose-Response Relationship, Drug; Drug Therapy, Combination; Electrocardiography; Female; Furans; Heart Rate; Humans; Male; Middle Aged; Propanolamines; Purinergic P1 Receptor Agonists; Time Factors; Treatment Outcome

2014

Noninvasive Assessment of Atrioventricular Nodal Function: Effect of Rate-Control Drugs during Atrial Fibrillation.

Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc, 2015, Volume: 20, Issue:6

Topics: Adenosine; Adrenergic beta-1 Receptor Antagonists; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrioventricular Node; Female; Furans; Humans; Male; Middle Aged; Propanolamines; Purinergic P1 Receptor Agonists

2015

Other Studies

1 other study(ies) available for tecadenoson and Auricular Fibrillation

Article	Year
Affinity and intrinsic efficacy (IE) of 5'-carbamoyl adenosine analogues for the A1 adenosine receptor--efforts towards the discovery of a chronic ventricular rate control agent for the treatment of atrial fibrillation (AF). Bioorganic & medicinal chemistry letters, 2004, Jan-19, Volume: 14, Issue:2 Topics: Adenosine; Animals; Atrial Fibrillation; Guinea Pigs; Heart Rate; Humans; In Vitro Techniques; Liver; Protein Binding; Rats; Receptor, Adenosine A1; Structure-Activity Relationship	2004

Article

Year

Affinity and intrinsic efficacy (IE) of 5'-carbamoyl adenosine analogues for the A1 adenosine receptor--efforts towards the discovery of a chronic ventricular rate control agent for the treatment of atrial fibrillation (AF).

Bioorganic & medicinal chemistry letters, 2004, Jan-19, Volume: 14, Issue:2

Topics: Adenosine; Animals; Atrial Fibrillation; Guinea Pigs; Heart Rate; Humans; In Vitro Techniques; Liver; Protein Binding; Rats; Receptor, Adenosine A1; Structure-Activity Relationship

2004